Robert J. Shovlin, President, Clinical Services at NEOGENOMICS INC (NEO), sold 252,986 shares at $17.05 ($4.3M) on 2018-11-09, disclosed to the SEC on 2018-11-13.
Open-market sale of $4.3M NEO by President, Clinical Services. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.05 | 180,000 | $3.1M | 71.5% |
| 2 | $16.76 | 36,493 | $612K | 14.2% |
| 3 | $16.76 | 36,493 | $612K | 14.2% |
| Total | $16.97 avg | 252,986 | $4.3M | 100% |
| Filing → |
| NEO | SELL | 2020-03-05 | $6.1M | — | Filing → |
| NEO | SELL | 2019-11-04 | $4.9M | — | Filing → |
| NEO | SELL | 2019-05-06 | $5.3M | — | Filing → |